Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Rasmussen, Birgitte B; Regan, Meredith M; Lykkesfeldt, Anne E; Dell'Orto, Patrizia; Del Curto, Barbara; Henriksen, Katrine L; Mastropasqua, Mauro G; Price, Karen N; Méry, Eliane; Lacroix-Triki, Magali; Braye, Stephen; Altermatt, Hans J; Gelber, Richard D; Castiglione-Gertsch, Monica; Goldhirsch, Aron; Gusterson, Barry A; Thürlimann, Beat; Coates, Alan S; Viale, Giuseppe; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2008
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial
Paridaens, Robert J; Gelber, Shari; Cole, Bernard F; Gelber, Richard D; Thürlimann, Beat; Price, Karen N; Holmberg, Stig B; Crivellari, Diana; Coates, Alan S; Goldhirsch, Aron
2010
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer
Regan, Meredith M; Neven, Patrick; Giobbie-Hurder, Anita; Goldhirsch, Aron; Ejlertsen, Bent; Mauriac, Louis; Forbes, John F; Smith, Ian; Láng, István; Wardley, Andrew; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Coates, Alan S; Thürlimann, Beat; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG)
2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J-M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S; BIG 1-98 Collaborative and International Breast Cancer Study Groups
2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
Annals of oncology : official journal of the European Society for Medical Oncology
Viale, Giuseppe; Regan, Meredith M; Maiorano, Eugenio; Mastropasqua, Mauro G; Golouh, Rastko; Perin, Tiziana; Brown, Robert W; Kovács, Anikó; Pillay, Komala; Ohlschlegel, Christian; Braye, Stephen; Grigolato, Piergiovanni; Rusca, Tiziana; Gelber, Richard D; Castiglione-Gertsch, Monica; Price, Karen N; Goldhirsch, Aron; Gusterson, Barry A; Coates, Alan S
2008
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer : predictive value of centrally reviewed expression of estrogen and progesterone receptors, international breast cancer study group
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer : a proof-of-concept trial (SAKK 23/03)
Giobbie-Hurder, Anita; Price, Karen N; Gelber, Richard D; International Breast Cancer Study Group; BIG 1-98 Collaborative Group
2009
Design, conduct, and analyses of Breast International Group (BIG) 1-98 : a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
Clinical trials : journal of the Society for Clinical Trials
Pestalozzi, Bernhard C; Zahrieh, David; Mallon, Elizabeth; Gusterson, Barry A; Price, Karen N; Gelber, Richard D; Holmberg, Stig B; Lindtner, Jurij; Snyder, Raymond; Thürlimann, Beat; Murray, Elizabeth; Viale, Giuseppe; Castiglione-Gertsch, Monica; Coates, Alan S; Goldhirsch, Aron; International Breast Cancer Study Group
2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast : combined results of 15 International Breast Cancer Study Group clinical trials
Gruber, G; Cole, B F; Castiglione-Gertsch, M; Holmberg, S B; Lindtner, J; Golouh, R; Collins, J; Crivellari, D; Thürlimann, B; Simoncini, E; Fey, M F; Gelber, R D; Coates, A S; Price, K N; Goldhirsch, A; Viale, G; Gusterson, B A; International Breast Cancer Study Group
2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
Regan, Meredith M; Price, Karen N; Giobbie-Hurder, Anita; Thürlimann, Beat; Gelber, Richard D; International Breast Cancer Study Group and BIG 1-98 Collaborative Group
2011
Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen N; Gelber, Richard D; Holmberg, Stig B; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin F; Murray, Elizabeth; Forbes, John F; Coates, Alan S; Goldhirsch, Aron; International Breast Cancer Study Group
2009
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
Thürlimann, Beat; Price, Karen N; Gelber, Richard D; Holmberg, Stig B; Crivellari, Diana; Colleoni, Marco; Collins, John; Forbes, John F; Castiglione-Gertsch, Monica; Coates, Alan S; Goldhirsch, Aron
2009
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
